Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Debra L. Murray is active.

Publication


Featured researches published by Debra L. Murray.


The Lancet | 1993

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

Donald Y.M. Leung; B.L Kotzin; H.C Meissner; R.D Fulton; Debra L. Murray; Patrick M. Schlievert

Kawasaki syndrome (KS), the main cause of acquired heart disease in children, is associated with the selective expansion of V beta 2+ T cells in peripheral blood. Our study suggests that KS may be caused by a superantigen--a staphylococcal or streptococcal toxin. Bacteria were cultured without knowledge of their origin, from the throat, rectum, axilla, and groin of 16 patients with untreated acute KS and 15 controls. Bacteria producing toxins were isolated from 13 of 16 KS patients but from only 1 of 15 controls (p < 0.0001). Toxic shock syndrome toxin (TSST) secreting Staphylococcus aureus was isolated from 11 of the 13 toxin-positive cultures, and streptococcal pyogenic exotoxin (SPE) B and C were found in the other 2. These toxins are known to stimulate V beta 2+ T cells. All TSST-producing KS isolates were tryptophan auxotrophs indicating they were clonally related. S aureus isolates from acute KS patients were unusual because they produced less lipase, haemolysin, and protease compared to other isolates (p < 0.01). S aureus colonies from KS patients were white, and could be easily mistaken for coagulase-negative staphylococci, whereas colonies of non-KS isolates were gold. These observations suggest that the expansion of V beta 2+ T cells in most patients with KS may be caused by a new clone of TSST-producing S aureus, and, in a minority of patients, SPEB-producing or SPEC-producing streptococci.


Experimental Eye Research | 1991

Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens

William B. Rathbun; Debra L. Murray

The study included human lenses of ages ranging from newborn to 92 years. Protein-free reduced glutathione decreased 14-fold, whereas protein-free oxidized glutathione increased 2.6-fold with increasing age. L-Cyst(e)ine uptake g-1 lens of very old cultured lenses decreased 70% from that exhibited in newborn lenses, demonstrating a marked decline of L-cyst(e)ine uptake as a function of age. In these same lenses the synthesis of reduced glutathione (mumol g-1 lens) decreased 73% with age. It was concluded that the glutathione decrease observed in the aging human lens was associated with decreased uptake of L-cyst(e)ine, decreased glutathione synthesis and possibly an increase in protein-free oxidized glutathione. The high correlation of L-cyst(e)ine uptake and glutathione synthesis supports the hypothesis that L-cyst(e)ine uptake is a rate-limiting factor of glutathione synthesis in the intact human lens. By the use of buthionine sulfoximine, the half-life of glutathione was estimated to be 90 hr in the cultured human lens.


Journal of Clinical Immunology | 1995

Molecular structure of staphylococcus and streptococcus superantigens

Patrick M. Schlievert; Douglas H. Ohlendorf; Cynthia V. Stauffacher; Donald Y.M. Leung; Debra L. Murray; Cathleen A. Earhart; Lynn M. Jablonski; Marcy L. Hoffmann; Young-In Chi

Staphylococcus aureus and streptococci, notably those belonging to group A, make up a large family of true exotoxins referred to as pyrogenic toxin superantigens. These toxins cause toxic shock-like syndromes and have been implicated in several allergic and autoimmune diseases. Included within this group of proteins are the staphylococcal enterotoxins, designated serotypes A, B, Cn, D, E, and G; two forms of toxic shock syndrome toxin-1 also made byStaphylococcus aureus; the group A streptococcal pyrogenic exotoxins, serotypes A, B, and C; and recently described toxins associated with groups B, C, F, and G streptococci. The nucleotide sequences of the genes for all of the toxins except those from the groups B, C, F, and G streptococcal strains have been sequenced. The sequencing studies indicate that staphylococcal enterotoxins B and C and streptococcal pyrogenic exotoxin A share highly significant sequence similarity; staphylococcal enterotoxins A, D, and E share highly significant sequence similarity; and toxic shock syndrome toxin-1 and streptococcal pyrogenic exotoxin B and C share little, if any, sequence similarity with any of the toxins. Despite the dissimilarities seen in primary amino acid sequence among some members of the toxin family, it was hypothesized that there was likely to be significant three-dimensional structure similarity among all the toxins. The three-dimensional structures of three of the pyrogenic toxin superantigens have been determined recently. The structural features of two of these, toxic shock syndrome toxin-1 and enterotoxin C3, are presented. Toxic shock syndrome-1 exists as a protein with two major domains, referred to as A and B. The molecule begins with a short N-terminalα-helix that then leads into a clawshaped structure in domain B that is made up ofβ strands. Domain B is connected to domain A by a central diagonalα-helix of amino acids which are important in both the superantigenic and the lethal activities of the toxin. Finally, domain A contains a wall ofβ strands and the C terminus of the molecule. The small N-terminalα-helix and the twoβ sheet structures (claw and wall) form part of a deep groove on the back side of the toxin that contains the centralα-helix. Staphylococcal enterotoxin C3 differs somewhat from toxic shock syndrome toxin-1: it has an elongated N terminus that folds over domain A, anα-helix at the base of domain B, a cysteine loop structure above the claw structure in domain B of toxic shock syndrome toxin-1, and a second centralα-helix.


Current Eye Research | 1990

Conditions for maximizing and inhibiting synthesis of glutathione in cultured rat lenses: an application of HPLC with radioisotope detection.

Debra L. Murray; William B. Rathbun

This investigation was concerned with factors which would maximize and inhibit L-cyst(e)ine uptake and glutathione synthesis of rat lenses cultured for 24 hours in a medium containing [35S]-L-cystine. The lenticular protein-free extract was separated and quantified by use of HPLC equipment which included an in-line radioisotope detector coupled with extensive post-run computer analysis. Six thiols were assessed for their ability to increase the uptake of L-cyst(e)ine and its utilization for glutathione synthesis. The most successful was 2-mercaptoethanol, which increased the L-cyst(e)ine uptake 3.6-fold and glutathione synthesis 2.9-fold. This work demonstrated that the rate of glutathione synthesis was directly proportional to the rate of uptake of L-cyst(e)ine. An inhibitor of glutathione synthesis, buthionine sulfoximine, in a concentration range of 0.11-3 mM, decreased uptake of the [35S]-label by one-third. The 3.0 mM concentration inhibited glutathione synthesis 98.7% and decreased glutathione 51% in 24 hours. The data indicate that half the glutathione disappeared in 23 hours in these cultured rat lenses. Because determination of this value did not depend upon the variable rate of cysteine transport, the value may approximate the in vivo value.


Biochemistry | 1993

STRUCTURE oF ToXIc SHocK SYNDROME ToXIN-1

G. Sridhar Prasad; Cathleen A. Earhart; Debra L. Murray; Richard P. Novick; Patrick M. Schlievert; Douglas H. Ohlendorf


Journal of Immunology | 1994

Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.

Debra L. Murray; G.S. Prasad; Cathleen A. Earhart; B. A. B. Leonard; Barry N. Kreiswirth; Richard P. Novick; Douglas H. Ohlendorf; Patrick M. Schlievert


Infection and Immunity | 1996

Localization of biologically important regions on toxic shock syndrome toxin 1.

Debra L. Murray; Cathleen A. Earhart; David T. Mitchell; Douglas H. Ohlendorf; Richard P. Novick; Patrick M. Schlievert


Biochemistry | 1998

Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity.

Cathleen A. Earhart; David T. Mitchell; Debra L. Murray; Denise M. Pinheiro; Masazumi Matsumura; Patrick M. Schlievert; Douglas H. Ohlendorf


Current Eye Research | 1990

Cysteine and glutathione metabolism in organ-cultured rat corneas

Jiali Li; William B. Rathbun; Debra L. Murray


Proteins | 1993

Growth and analysis of crystal forms of toxic shock syndrome toxin 1

Cathleen A. Earhart; G. Sridhar Prasad; Debra L. Murray; Richard P. Novick; Patrick M. Schlievert; Douglas H. Ohlendorf

Collaboration


Dive into the Debra L. Murray's collaboration.

Top Co-Authors

Avatar

Patrick M. Schlievert

Roy J. and Lucille A. Carver College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge